Metabolic side effects of second-generation antipsychotics in children and adolescents: a different story?
Correll
Christoph U
CU
The Zucker Hillside Hospital, Glen Oaks, NY 11004, USA. ccorrell@lij.edu
D000293:Adolescent; D000367:Age Factors; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D001823:Body Composition / Q000187:drug effects; D015992:Body Mass Index; D002648:Child; D003376:Counseling; D015444:Exercise; D005260:Female; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy / Q000378:metabolism; D024821:Metabolic Syndrome / Q000139:chemically induced / Q000175:diagnosis; D009765:Obesity / Q000139:chemically induced* / Q000175:diagnosis / Q000378:metabolism / Q000517:prevention & control; D015430:Weight Gain / Q000187:drug effects*
D014150:Antipsychotic Agents